| __timestamp | ACADIA Pharmaceuticals Inc. | Agios Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 100371000 |
| Thursday, January 1, 2015 | 76369000 | 141827000 |
| Friday, January 1, 2016 | 4406000 | 220163000 |
| Sunday, January 1, 2017 | 13060000 | 292681000 |
| Monday, January 1, 2018 | 18330000 | 1397000 |
| Tuesday, January 1, 2019 | 19598000 | 1317000 |
| Wednesday, January 1, 2020 | 20550000 | 2805000 |
| Friday, January 1, 2021 | 19141000 | 18777000 |
| Saturday, January 1, 2022 | 10166000 | 1704000 |
| Sunday, January 1, 2023 | 45731000 | 9504000 |
| Monday, January 1, 2024 | 4165000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. This analysis delves into the cost of revenue trends for ACADIA Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, ACADIA's cost of revenue fluctuated, peaking in 2015 and 2023, while Agios experienced a significant spike in 2017, with costs nearly tripling compared to 2014.
These trends highlight the dynamic nature of cost management in the pharmaceutical industry, where strategic decisions can lead to significant financial efficiencies.
Johnson & Johnson vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Agios Pharmaceuticals, Inc.
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored